AIM2 and Wilson disease: In this murine study, we show that AIM2 inflammasome activation is critically involved in NMU-induced retinal photoreceptor degeneration and that WD treatment offers cytoprotection, which is, in part, achieved through the suppression of AIM2 inflammasome activation.